NEWS RELEASE

2021.02.22

Gannex Announces Positive Clinical Results in Overweight and Obese Subjects for Its THR-b Agonist ASC41

Gannex (Shanghai, China) has announced positive clinical results in overweigth and obse subjects for its THR-b agonist ASC41.

 

For detail information, see the Gannex's press release.

https://www.ascletis.com/news_detail/175/id/462.html